Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
UBAB, LOAN, FITB, More
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for the quarter came in at $36.4 million versus the consensus estimate of $31.51 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Bright Horizons (BFAM) PT Lowered to $87 at UBS Ahead of Q2 Results
- VIST Financial Corp. (VIST) Misses Q2 EPS by 76c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
